BCL2L1 and neoplasm: In contrast, the mice injected cells treated with miR-106b-5p had more considerable tumor burden than controls (Figures 6(b) and 6(c)) and displayed higher expression for Ki67, PCNA, Bcl-xL, and cyclin E1, along with a lower expression for BTG3 in tumor tissues relative to controls (Figures 6(d) and 6(e)).